![Mahalakshmi Radhakrishnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Mahalakshmi Radhakrishnan ocupa el cargo de Directora Médica y Vicepresidenta Senior del Grupo en Biogen, Inc. La Dra. Radhakrishnan también es Vicepresidenta Senior y Directora Médica Mundial de Bioverativ Therapeutics, Inc. En su anterior carrera, la Dra. Radhakrishnan ocupó el cargo de Vicepresidenta de Biogen, Inc., Directora Mundial de la Unidad de Negocio de Atención Médica y Primaria de Sanofi y Directora Ejecutiva y Jefa del Área Terapéutica de Bristol-Myers Squibb Holdings Pharma LLC. Mahalakshmi Radhakrishnan se doctoró en la Universidad de la Amistad de los Pueblos de Rusia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/06/2025 |
| CANDEL THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/06/2025 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Director/Miembro de la Junta | 29/11/2022 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Director/Miembro de la Junta | 05/01/2023 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Inversor de Capital Privado | 01/08/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Director/Miembro de la Junta | 13/05/2025 |
| BIOGEN INC. | Director Técnico/Científico/I+D | 01/03/2024 |
| SANOFI | Corporate Officer/Principal | 01/01/2019 |
| BIOASIS TECHNOLOGIES INC. | Director/Miembro de la Junta | 27/07/2018 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Peoples' Friendship University of Russia
 Peoples' Friendship University of Russia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Bristol-Myers Squibb Holdings Pharma LLC
 Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
